FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form Is a Type of drug preparation false Inferred relationship Existential restriction modifier
    Cutaneous AND/OR transdermal dosage form Is a Dose form by site prepared for false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Betamethasone valerate 0.1% / Neomycin 0.5% ointment (Essential Generics Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Amorolfine 5% medicated nail lacquer (Aspire Pharma Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Aciclovir 5% cream (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Amorolfine 5% medicated nail lacquer (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Terbinafine 1% cream (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Metronidazole 0.75% gel (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mometasone 0.1% cream (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mometasone 0.1% ointment (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Calcipotriol 50micrograms/ml scalp solution (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Piroxicam 0.5% gel (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.1% / Neomycin 0.5% cream (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.1% / Neomycin 0.5% ointment (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Amorolfine 5% medicated nail lacquer (Genus Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% cream (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% cream (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% ointment (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% ointment (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% ointment (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5mg muco-adhesive buccal tablets sugar free (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuprofen 10% gel (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuprofen 5% gel (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ketoprofen 2.5% gel (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.1% / Neomycin 0.5% cream (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.1% / Neomycin 0.5% ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Adapalene 0.1% gel (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Amorolfine 5% medicated nail lacquer (Actavis UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Piroxicam 0.5% gel (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Metronidazole 0.75% gel (AM Distributions (Yorkshire) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Cetrimide 1% topical liquid (Special Order) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.025% cream (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.025% ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% cream (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mometasone 0.1% cream (Teva UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Audavate RD 0.025% ointment (Accord Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Audavate RD 0.025% cream (Accord Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Aciclovir 5% cream (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Adapalene 0.1% gel (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Potassium hydroxide Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Potassium hydroxide 5% solution Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    MolluDab 5% solution (Alliance Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Amorolfine 5% medicated nail lacquer (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Calcipotriol 50micrograms/ml scalp solution (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Piroxicam 0.5% gel (Actavis UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clobavate 0.05% ointment (Auden McKenzie (Pharma Division) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clobetasone 0.05% ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Sancuso 3.1mg/24hours transdermal patches (ProStrakan Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Chlorhexidine gluconate 4% solution (AM Distributions (Yorkshire) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Lidocaine 2.5% / Prilocaine 2.5% cream (AM Distributions (Yorkshire) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Denela 5% Cream (Auden McKenzie (Pharma Division) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Metronidazole 0.75% gel (J M McGill Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hapoctasin 35micrograms/hour transdermal patches (Accord Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hapoctasin 52.5micrograms/hour transdermal patches (Accord Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hapoctasin 70micrograms/hour transdermal patches (Accord Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Opiodur 25micrograms/hour transdermal patches (Pfizer Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Opiodur 75micrograms/hour transdermal patches (Pfizer Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Opiodur 100micrograms/hour transdermal patches (Pfizer Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Opiodur 50micrograms/hour transdermal patches (Pfizer Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fentanyl 25micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fentanyl 50micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fentanyl 75micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fentanyl 100micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Molutrex 5% solution (Espere Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Amorolfine 5% medicated nail lacquer (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clobetasol 0.05% cream (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clobetasol 0.05% ointment (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estradot 50micrograms/24hours patches (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Tetracaine 1% cream (Special Order) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ketoprofen 2.5% gel (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Coal tar extract 2% shampoo (AM Distributions (Yorkshire) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Metronidazole 0.75% gel (Niche Pharma Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Metronidazole 0.75% gel (CST Pharma Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Cutivate 0.05% cream (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5mg muco-adhesive buccal tablets sugar free (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% cream (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% cream (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% cream (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% ointment (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% ointment (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% ointment (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuprofen 10% gel (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Metronidazole 0.75% gel (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mometasone 0.1% cream (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mometasone 0.1% ointment (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mupirocin 2% ointment (DE Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dovobet gel (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Care Haemorrhoid Relief suppositories (Thornton & Ross Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mylafent 50micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mylafent 75micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mylafent 100micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Numark Cold Sore 5% cream (Numark Management Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Methyl salicylate 25% liniment (Special Order) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Methyl salicylate 50% ointment (Special Order) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Piroxicam 0.5% gel (Auden McKenzie (Pharma Division) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Numark Ibuprofen Pain Relief 5% gel (Numark Management Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Metronidazole 0.75% gel (Cubic Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Balneum Plus cream (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nystatin 100,000units/g cream (Special Order) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier

    Start Previous Page 52 of 55 Next End


    This concept is not in any reference sets

    Back to Start